共 25 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 43473-012-01 | EVERLIT CARE Triple Antibiotic | OINTMENT | 2023-10-14 | M004 |
| 2 | 43473-014-01 | GENUINE FIRST AID Antibiotic | OINTMENT | 2023-10-18 | M004 |
| 3 | 43473-016-01 | FIRSTAR TRIPLE ANTIBIOTIC | OINTMENT | 2023-11-18 | M004 |
| 4 | 43473-050-01 | health and .beyond Triple Antibiotic | OINTMENT | 2025-07-27 | M004 |
| 5 | 43473-053-01 | AOSI HEALTHCARE TRIPLE ANTIBIOTIC | OINTMENT | 2024-09-24 | M004 |
| 6 | 43473-061-01 | OP First Aid Series TRIPLE ANTIBIOTIC | OINTMENT | 2024-12-05 | M004 |
| 7 | 43473-067-01 | PROHEAL TRIPLE ANTIBIOTIC | OINTMENT | 2025-01-17 | M004 |
| 8 | 43473-063-01 | health and beyond TRIPLE ANTIBIOTIC | OINTMENT | 2025-01-04 | M004 |
| 9 | 43473-068-01 | The Life Safety Pro Triple Antibiotic | OINTMENT | 2025-02-18 | M004 |
| 10 | 43473-301-01 | Lightning X Triple Antibiotic | OINTMENT | 2024-01-08 | M004 |
| 11 | 43473-314-01 | SurviveX Triple Antibiotic | OINTMENT | 2025-08-08 | M004 |
| 12 | 43473-312-01 | Meret Triple Antibiotic | OINTMENT | 2025-06-25 | M004 |
| 13 | 43473-559-01 | SurviveX Triple Antibiotic | OINTMENT | 2026-09-02 | M004 |
| 14 | 43473-011-01 | EVERLIT CARE Hand Sanitizer | GEL | 2023-10-14 | M005 |
| 15 | 43473-041-01 | MY MEDIC SUPER SANITIZER | GEL | 2024-07-02 | M005 |
| 16 | 43473-052-01 | COTTON ON FOUNDATION Coastal Hand Sanitizer | SPRAY | 2024-09-04 | M005 |
| 17 | 43473-051-01 | COTTON ON FOUNDATION Tropical Hand Sanitizer | SPRAY | 2024-09-04 | M005 |
| 18 | 43473-056-01 | AOSI HEALTHCARE HAND SANITIZER | GEL | 2024-09-25 | M005 |
| 19 | 43473-057-01 | MY MEDIC SUPER SANITIZER | GEL | 2024-10-02 | M005 |
| 20 | 43473-075-01 | health beyond HAND SANITIZER | GEL | 2025-03-27 | M005 |
| 21 | 43473-089-01 | EVERLIT CARE Hand Sanitizer | GEL | 2025-10-25 | M005 |
| 22 | 43473-093-01 | Beauty Creations Pink Halo Hand Sanitizer Mist | SPRAY | 2026-01-04 | M005 |
| 23 | 43473-122-01 | Lightning X Hand Cleanser | GEL | 2026-05-11 | M005 |
| 24 | 43473-094-02 | 0.25 % PHENYLEPHRINE HCl HEMORRHOIDAL | OINTMENT | 2026-02-05 | M015 |
| 25 | 43473-100-04 | ORAL PAIN RELIEF | GEL | 2026-01-20 | M022 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系